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Introduction 
Fetal growth can be defined in 
terms of changes in newborn size, 
organ growth, and maturation, and 
by the many biochemical adap-
tations that prepare the fetus for 
extrauterine existence. Intrauter-
ine growth retardation (IUGR) can 
result from environmental and ge-
netic influences that limit the intrin-
sic potential of the fetus to grow, or 
that restrict growth because of de-
creases in the amount of available 
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nutrients. IUGR is most commonly 
defined as a birth weight of less 
than the tenth percentile at a given 
gestational age. It is only within the 
past 20 to 25 years that clear dis-
tinctions have been made be-
tween low birth weight caused by 
IUGR and that due to preterm 
labor. There may be a consid-
erable overlap between IUGR and 
preterm delivery, which refers to 
birth at less than 38 weeks' gesta-
tion, largely because some of the 
same risk factors are common to 
both conditions. Teenage preg-
nancy, for example, may result in 
high risk for both prematurity and 
IUGR. Prognosis of IUGR depends 
on the underlying condition to a 
major degree. 
Influences on Fetal Growth 
A variety of genetic and environ-
mental factors affect fetal 
growth,' 2 Genetic factors may be 
responsible for species or popu- 
continued on page 5 
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diseases of the GI tract and their 
resultant inhibition of good nutri-
tion and normal growth. Many 
children in Guatemala, Bangla-
desh, and northeastern Brazil ex-
perience from six to nine episodes 
of diarrhea per year during their 
first three years of life.1-3 Most epi-
sodes last for a few days and re-
solve without serious conse- 
quences. Other incidents result in 
considerable losses of fluids and 
electrolytes or are accompanied 
by fever, anorexia, and consid-
erable damage to the intestinal 
mucosa. The worst episodes yield 
sequelae and permanent dam-
age, such as growth retardation, or 
result in death. 
continued on page 2 
The predominant etiology of diar-
rhea in the general population of 
underdeveloped countries is in- 
it.., 	 fection by viruses and bacteria. 
Studies in rural areas clearly sug-
gest an infectious cause. For ex-
ample, diarrhea initially affects one 
individual in the family (index 
case) and then spreads to other 
family and community members. 
Infants and toddlers are affected 
more frequently than older chil-
dren, adolescents, and adults. The 
4,40/ high prevalence of diarrhea in 
populations with poor personal 
hygiene and deficient environ-
mental sanitation also points to an 
infectious cause and is supported 
by the identification of rotaviruses, 
Campylobacter, enterotoxigenic 
enteric bacteria, Cryptosporidium, 
Shigella, Vibrio cholerae, Salmo-
nella, Giardia, and other parasites 
in most patients with diarrhea. 
Longitudinal studies of children 
in deprived ecosystems have 
documented the significance of 
diarrheal disease in respect to 
poor nutrition and growth.1-3 
These studies reveal not only the 
frequency of diarrhea in infants 
%NO 	 and young children but also the 
severity of damage from infectious 
Figural. Typical growth pattern of a Guatemalan village child. Note the drop-off in 
growth at about five months when the child was weaned from breast milk. 
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Effect of Diarrhea on Growth 
Upon detection of growth defi-
ciency or failure to thrive, pediatri-
cians in industrial nations rarely 
consider infection as the first diag-
nostic possibility, In these nations, 
most problems of growth failure 
due to gastrointestinal distur-
bances are related to physiologic, 
enzymatic, immunologic, or meta-
bolic alterations of a noninfectious 
nature' rather than infectious 
causes. 
In developing countries, how-
ever, the situation is quite 
different—particularly in infants 
who are not breast-fed. Interest-
ingly, most breast-fed children 
grow very well, even under ex-
treme poverty.' By contrast, most 
children in poor rural and urban 
areas who are not breast-fed suffer 
several diarrheal episodes each 
year, usually resulting in weight 
loss. Diarrhea-induced weight loss 
is difficult to correct without 
prompt and adequate nutritional 
dietary therapy. Diarrhea often 
persists in children, even after cor-
rection of the infection. This persis-
tence and recurrence of diarrheal 
episodes generally do not permit 
catch-up growth. This sequence of 
events is exemplified by the typical 
Guatemalan village child whose 
growth is illustrated in Figure 1 .5 In 
many rural areas, from 5% to 20% 
of the diarrheas persist for several 
days or weeks because of Shigella 
infections. Unfortunately, appro-
priate antibiotic therapy required 
for resolution of these infections is 
not available in most poor rural 
areas. 
Another possible factor in per-
sistent diarrhea is lactose intoler-
ance—a frequent finding, particu-
larly in viral diarrhea during the first 
year of life. For these infants, diar-
rhea persists for as long as they 
are fed cows' milk. 
The Guatemalan boy whose 
growth curve is diagrammed in 
Figure 1 grew well during the 
period of exclusive breast-feeding 
and his growth parameters fell 
along the 50th percentile of the  
growth chart of the National Center 
for Health Statistics (NCHS). When 
food supplementation was begun 
at approximately 6 months of age, 
however, a continuum of diarrheal 
episodes and weight loss was ob-
served in connection with recur-
ring gastrointestinal and upper 
respiratory infections. By 1 year of 
age, the child had experienced 
several bacterial and viral infec-
tions, and altered physical growth 
was apparent.° In addition, infec-
tion with parasitical organisms, 
such as round worms, may also 
disturb normal growths and may 
have contributed to alterations in 
this child. 
By age 1, the child was distinctly 
wasted. The encounter with a vari-
ety of viruses, bacteria, and para-
sites continued, and for one year 
the child remained wasted and at 
risk of developing severe protein-
energy malnutrition or of dying. 
The possible metabolic and hor-
monal disturbances in children 
under such circumstances—who 
represent the majority of cases in 
deprived villages and slums—
have not been established. 
Field studies show that diarrhea 
adversely affects nutrition and 
physical growth.7-9 Figure 2 illus- 
trates the relationship of growth 
retardation to diarrheal episodes 
in two Cauque children. Each re-
corded episode of diarrhea of 
known or unknown etiology co-
incided with an arrest in linear 
growth. These arrests were of 
shorter duration and negligible 
consequence during the first 
months of exclusive, intensive 
breast-feeding; upon weaning, 
however, the magnitude of ar-
rested growth was more marked, 
often extending for several weeks 
or months, The effect was even 
more pronounced in the child with 
severe fetal growth retardation, as 
seen in the right side of Figure 2. 
These cases demonstrate the 
prolonged effects of inadequately 
treated diarrhea and the lack of 
rapid catch-up growth because 
the child is repeatedly stricken 
with infectious episodes, Eventu-
ally, the cumulative effects of these 
episodes (with the additive effects 
of otitis media, acute respiratory 
infections, or exanthemas of early 
childhood) result in a markedly 
diminished growth rate. In the 
study village, virtually all children 
showed some degree of stunting 
	 Nil le,  
by age 2 years. Cohorts defined by 
birth weight or by fetal maturity 
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Figure 2. The relationship of drop-offs in growth to infectious diseases is clearly illustrated in these two children. 
The effect is more pronounced in the pattern on the right of a child with severe fetal retardation. 
\me 90 	  90 
40 
PIK 
ippsA 
40 
INISA 
0 3 6 9 12 15 18 21 24 	 3 6 9 12 15 IS 21 24 
MONTHS 
	 MONTHS 
exhibited a positive correlation be-
tween intrauterine growth and 
poor postnatal physical growth..' 
The greatest impact is delivered 
by the adverse microbial environ-
ment of underdeveloped coun-
tries.1:5 Overall growth deficit and 
much of the wasting reported in 
children throughout the world is 
probably the result of repetitive di-
arrhea' diseases and other infec-
tions, which severely aggravate an 
already marginal or poor nutri-
tional intake. 
A long-term study, conducted in 
the poor, rural population of Costa 
Rica, a country in transition, dem-
onstrated that growth was signifi-
cantly improved as better sani-
tation was developed.9 Although 
food supplementation during 
weaning frequently was not im-
proved, the less intense infectious 
environment resulted in very low 
rates of enteric infection and diar-
rheal disease.1° While growth fail-
ure was occasionally observed, it 
was the exception and was attrib-
utable to organic disorders or child 
%119 
	
	 neglect, as is the case in industrial 
nation s .9  
Infectious Diarrhea Induces 
Malnutrition 
Diarrheal diseases are the most 
important inducers of malnutrition 
worldwide, because they alter 
nutrition—and growth—through 
reduced food intake, disturbed di-
gestion and absorption, impaired 
use of nutrients, and other meta-
bolic alterations. Each episode 
has a varying impact on the host 
economy and nutrition, even when 
there is no limitation in food avail-
ability.' Diminished intake of food 
during diarrheal episodes is often 
substantial, especially among in-
fants and toddlers. There are two 
predominant causes: anorexia 
and restriction dictated by tradi-
tions, beliefs, and taboos. In the 
latter case, the mother or other 
caretaker suppresses the food in-
take for days or even weeks, in the 
belief that food perpetuates the 
diarrhea. 
Anorexia appears to be the most 
significant reason for decreased 
food consumption. It is triggered 
by frnerleukin 1 (previously known 
as leukocyte endogenous medi-
ator) and by cachectin (tumor  
necrosis factor), hormone-like 
substances released by macro-
phages and monocytes under the 
stimulus of infections or other 
stress. A manifestation of the 
"generalized acute-phase meta-
bolic response," anorexia occurs 
regardless of the type, severity, 
and localization of infection.11  
Most foods are rejected, although 
breast milk is least so. The intensity 
of anorexia does not always cor-
relate with the kind or severity of 
illness, and a child may become 
anorectic even with a common 
cold or mild diarrhea. The effect 
may last a few hours or extend for 
days or weeks. As much as 20% to 
70% of the available food may be 
wasted or uneaten during bouts of 
diarrhea.' 
Microbial action also increases 
intestinal secretion and lysis of 
cells in villous tips by rotaviruses. 
for example, or by stimulation of 
cyclic AMP and cyclic GMP by 
bacterial enterotoxins such as 
Escherichia coli. If repetitive 
losses are not corrected by re-
hydration and other therapies-- 
continued on page 4 
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often unavailable in villages in 
poor countries-they contribute to 
malnutrition. Hypersecretion also 
can be induced by bile and fatty 
acids, hormones, and neuro-
transmitters, and by greater cal-
cium cell permeability induced by 
mediators.' 2 Agents such as Giar-
dia adhere to the surface of entero-
cytes, while others such as Cryp-
tosporidium lodge under the 
microcalix but outside the cyto-
plasm. Some parasites multiply 
within epithelial cells and in the 
lamina propria, causing inflamma-
tion and bleeding (Shigella), or 
burrow in tissue, eliciting a granu-
lomatous response (Entamoeba), 
or they reach lymph and blood 
vessels, resulting in sepsis 
(Salmonella). 
These infections may generate 
profuse loss of water, electrolytes, 
cells, and nutrients, reducing the 
host to a state of acute malnutri-
tion. Patients, especially infants 
and young children, may lose 10% 
or more of their body weight within 
hours, and may die if shock and 
dehydration are not promptly cor-
rected. Cells, plasma, amino ac-
ids, lipids, vitamins, and hormones 
may be lost with injury to intestinal 
mucosa. The dysentery diarrheas 
are more damaging because they 
often are accompanied by a 
protein-losing enteropathy,13 and 
exhibit toxic manifestations with 
weakness and prostration and 
high mortality. 
As with other infections, diar-
rhea is accompanied by anorexia 
and fever, breakdown of muscle 
protein, discharge of insulin and 
glucagon, mobilization of leuko-
cytes, and sequestration of zinc 
and iron. Vasoactive intestinal 
polypeptide (VIP), which inhibits 
the peristaltic reflex, and other gut 
hormones (motilin, enterogluca-
gon, and neurotensin) are in-
creased or decreased during diar-
rhea. Prostaglandins are increased 
in diarrhea, including the mild 
forms seen in toddlers.14 
Conclusion 
Infectious diseases, and diarrhea  
in particular, are the main deter-
minants of wastage and stunting of 
growth in children in underdevel-
oped countries. Nations that are 
able to diminish the incidence of 
diarrhea and other infections 
clearly exhibit a secular change in 
growth and height of children, as 
observed in Chile, Costa Rica, and 
other 	 countries 	 in 	 rapid 
transition.5,15'16  Children with no or 
fewer infections have better appe-
tites, and their healthy parents 
provide better care. In turn, society 
benefits because of better use of 
available resources and increases 
in production. This might explain, 
in part, why certain very poor ar-
eas, which remain basically poor 
and consume minimal food, ex-
hibit a remarkably good health 
condition. One example is the 
State of Kerala in India,' 
Equally interesting is the obser-
vation that in some undeveloped 
countries, provision of food sup-
plementation or food distribution 
centers has been unsuccessful in 
combating malnutrition. in particu-
lar, this is especially noticeable in 
the continuing presence of poor 
sanitation, which leads to diarrhea 
and other infectious diseases. As 
part of any major policy to prevent 
malnutrition in underdeveloped 
countries, attention must be di-
rected toward the control of infec-
tious diarrhea. Only in this way can 
malnutrition and growth failure be 
prevented.5'17 
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part of the symptom complex 
caused by toxoplasmosis, con-
genital syphilis, rubella, cyto-
megalovirus, and herpes simplex 
(the TORCH organisms). Recently, 
IUGR-associated malformations, 
including microcephaly and cra-
niofacial abnormalities, have been 
described in newborns with an 
AIDS-related embryopathy.3 
Drugs and chemicals causing 
IUGR include classic teratogens, 
such as antimetabolites, as well as 
common therapeutic agents such 
as phenytoin, trimethadione, and 
warfarin. Heroin addiction, ciga-
rette smoking, and heavy alcohol 
use are also commonly associated 
with IUGR, More than 50% of in-
fants born to mothers who drink 
heavily will be abnormal. In one 
study, the incidence of IUGR was 
7% in babies whose mothers were 
light-to-moderate drinkers and 
27% in those whose mothers were 
heavy drinkers.4 Cigarette smok-
ing is a powerful determinant of 
IUGR and results in a birth weight 
deficiency of 150 to 250 g,b This is 
most likely related to the combined 
effects of smoking on maternal 
appetite, uteroplacental blood 
flow, and maternal blood levels of 
carbon monoxide that further im-
pair oxygen delivery to the fetus. 
The terms "proportionate" and 
"disproportionate" have been 
used to distinguish IUGR new-
borns with decreased growth po-
tential from those with restricted 
growth due to impairment of ma-
ternal nutrient delivery. Fetuses 
and newborns with decreased nu-
trient supplies exhibit dispro-
portionate growth because of a 
relative sparing of brain growth, 
whereas congenital infections or 
genetic diseases that restrict 
growth potential result in propor-
tionate or symmetrical growth re-
tardation. These patterns of 
growth can be detected in utero 
and may indicate the underlying 
condition that ultimately results in 
IUGR. Poor maternal weight gain 
and fundal growth should alert the 
obstetrician to the likelihood of 
IUGR so that ultrasonography can 
be utilized to follow fetal growth 
parameters such as the biparietal 
diameter or the relationship of the  
head size to the body size (which 
can be used to identify proportion-
ate or disproportionate fetal 
growth in utero). 
Fetal Malnutrition 
Fetal malnutrition is the most 
common cause of low birth weight. 
it can result from maternal malnu-
trition or from failure of the fetal 
circulation to deliver adequate 
substrates to the fetus generally 
because of maternal diseases that 
restrict uteroplacental blood flow. 
Conditions resulting in decreased 
uteroplacental blood flow include 
toxemia of pregnancy and mater-
nal hypertension secondary to 
chronic renal disease. Fetuses in 
multiple pregnancies may exhibit 
restricted growth because of fail-
ure of the uteroplacental unit to 
provide optimal nutrition to more 
than one fetus in the uterus. The 
smaller twin of a monozygotic pair 
frequently exhibits IUGR because 
of arteriovenous communications 
within the chorionic plate that can 
severely compromise blood flow to 
one twin. IUGR is also observed in 
infants born in high-altitude re-
gions and in those born to mothers 
with cyanotic congenital heart dis-
ease, presumably because less 
oxygen is available in both 
instances. 
Maternal Regulation of Growth 
Walton and Hammonds reported 
that foals of Shire horses bred with 
Shetland ponies reflected the size 
of the mother. Shetland/Shire 
crosses born to a Shire mare were 
the size of normal Shire foals, 
whereas the foals born to the Shet-
land dam and the Shire cross were 
the size of the normal Shetland 
foal. Similar data in other species, 
including humans, suggest that 
constraints on fetal growth are im-
posed by the maternal uterine en-
vironment. In human pregnancies, 
fetal growth is generally not af-
fected by the number of fetuses 
prior to the 26th week of gestation. 
After 27 weeks of gestation. how-
ever, the growth rate is slowed for 
triplets; the rate slows after 30 
weeks for twins. Uteroplacental 
constraints may even become op- 
continued on page 6 
lation differences in size at birth. 
Mean birth weight in human popu-
lations can range from 2,400 g 
in New Guinea to 3,880 g in Ameri-
can Indian populations, Although 
some of these differences can be 
explained by factors such as nutri-
tion and maternal size, it is likely 
that ethnic differences in birth 
weight occur regardless of socio-
economic status. Males weigh an 
average of 150 to 200 g more than 
females at birth. This difference 
occurs in late gestation and may 
be related to the testosterone pro-
duced by the male gonad, but this 
has not been proven. 
4%mort 
	
	 Hormones are important for fetal 
maturation and for many of the 
adaptive events that prepare the 
fetus for extrauterine existence. 
Insulin appears to be the principal 
growth hormone for the fetus. 
Other classic hormones appear to 
influence specific organ develop-
ment rather than fetal size. For 
example, testosterone induces vir- 
*or 
ilization of the genitalia, gluco-
corticoid influences lung matura-
tion, and thyroxine modulates 
central nervous system develop-
ment. With the exception of so-
matomedins, other putative 
growth factors, including epi-
dermal growth factor, nerve 
growth factor, and transforming 
growth factors, are of likely impor- 
lev tance in regulating organ growth 
and differentiation without greatly 
influencing newborn size. So-
matomedins are present in and 
synthesized by a variety of fetal 
tissues, and umbilical cord levels 
of somatomedin-C have been cor-
related with birth weight. 
Genetic and/or chromosomal 
disorders can profoundly alter fe-
tal growth, with the degree of 
growth failure reflecting the spe-
cific defect. Growth retardation is a 
major feature of Down's syndrome, 
trisomies 13 and 18, and Turner's 
syndrome. Intrauterine infections 
may be responsible for as many as 
10% of cases of IUGR and should 
always be considered in the eval-
uation. IUGR is commonly seen as 
5 
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erative in singleton pregnancies 
when a weight of about 3,000 g is 
achieved regardless of the num-
ber of fetuses. 
The Dutch famine of 1944-45 
resulted in a mean birth weight 
reduction of about 300 g.7 This 
effect was observed primarily 
when the period of starvation oc-
curred within the last trimester of 
pregnancy. Behavioral testing and 
10 performance data did not re-
veal any deficiencies when the 
population at risk was studied 
more than 20 years later. 
IUGR caused by malnutrition 
may be multigenerational. In a 
marginally nourished rat colony 
maintained over nine generations, 
maternal weights and newborn 
sizes were markedly reduced 
when compared with those in nor-
mally nourished controls.8 With re-
institution of normal nutrition after 
five generations of marginal nutri-
tion, it appeared that more than 
one generation of good feeding 
was necessary to correct the 
deficits. 
Clinical Evaluation of IUGR 
Evaluation of the newborn with 
IUGR begins with measuring 
length, weight, and head circum-
ference and plotting the results on 
standard growth charts to deter-
mine if the pattern of growth is 
disproportionate or proportionate. 
The Lubchenco charts are most 
commonly used although they 
may underestimate IUGR as com-
pared with other standards. A 
careful assessment of gestational 
age should be made for all infants. 
Accurate dates can be confirmed 
by ultrasound examination of the 
fetus in early pregnancy or esti-
mated less precisely by the Du-
bowitz exam immediately after 
birth. 
Infants with nutritional IUGR 
have a scrawny, wasted ap-
pearance because they have so 
little subcutaneous fat. Many of 
their problems are associated with 
decreased metabolic reserves. 
These infants are at increased risk  
for asphyxia and meconium as-
piration; therefore, when IUGR is 
detected antenatally, there should 
be appropriate monitoring and 
careful planning concerning the 
mode of delivery. 
Newborns with !UGH are also at 
increased risk for hypoglycemia 
and polycythemia. Hypoglycemia 
is probably due to low fuel re-
serves and a decreased capacity 
to carry out gluconeogenesis. 
Polycythemia occurs in response 
to the increased erythropoietin 
levels secondary to relative intra-
uterine hypoxia. Chronic intrauter-
ine hypoxia may also result in per-
sistent pulmonary hypertension 
with marked right-to-left shunting 
because of abnormal thickening of 
the small pulmonary arterioles in 
the hypoxic fetus. These are pri-
marily problems of the nutritionally 
growth-retarded newborn. Those 
with IUGR secondary to congenital 
infection and/or genetic disorders 
are less likely to develop these 
complications. 
Fetal Adaptation in IUGR 
While serious pathology may 
clearly be the consequence of 
markedly reduced uteroplacental 
blood flow, the majority of infants 
with nutritionally based IUGR have 
normal development and do not 
show significant differences in IQ 
or neurological scores when com-
pared with normal newborns.9 A 
strong case can be made that 
many of the features of nutritional 
IUGR represent fetal adaptation to 
a restricted nutrient environment 
rather than a pathologic condi-
tion.1° Those fetuses with suf-
ficient time to adapt to compro-
mised nutrition may maximize their 
prospects for a favorable outcome. 
In such infants, brain growth is 
spared because of a redistribution 
of fetal blood flow. A smaller over-
all fetal size may reduce substrate 
and oxygen needs to what can be 
provided by an impaired utero-
placental circulation. A redis-
tribution of blood flow to the head 
supports brain growth and head 
circumference at the expense of 
both weight and linear growth. In-
creased blood flow to the brain 
associated with decreased blood  
flow to the viscera increases the 
ratio of head circumference to ab-
dominal circumference; this ratio 
can be measured in utero with ul- 	 "tt 
trasound and thus identifies dis-
proportionate IUGR antenatally. 
Vasopressin released in response 
to oxygen and/or nutrient defi-
ciency is a likely mediator of in-
creased blood flow to the brain. 
Polycythemia exhibited by these 
infants can also be viewed as an 
adaptation that results in an in-
crease in the capacity of the blood 
to carry oxygen to the organs and 
tissues of the growth-restricted 
fetus. 
Finally, severe nutrient restric-
tion appears to be associated with 
accelerated maturation. Data from 
experimental animals and in hu-
mans suggest a lower incidence of 
hyaline membrane disease in fe-
tuses with IUGR, which may in-
crease survival if the fetus with 
IUGR is born prematurely. The in-
fant with IUGR may therefore rep-
resent a successful adaptation to 
a substrate-deficient intrauterine 
environment. Those infants with 
IUGR who have sufficient time to 
adapt to a substrate-deficient in-
trauterine environment may be at 
lower risk for serious hypoxic injury 
that may occur in large fetuses 
born at term but subjected to acute 
uteroplacental compromise at the 
time of delivery. In other words, 
smaller may be better. 
If maternal constraints on fetal 
growth can be viewed as an adap-
tation in the IUGR pregnancy, 
questions can be raised about the 
effects of intervention programs 
designed to increase fetal 
weights. This may potentially 
cause an adverse outcome in 
chronically malnourished popu-
lations that have already adapted 
to malnutrition and a constrained 
uterine environment. Careful eval-
uation and follow-up of such inter-
vention programs are necessary. 
In summary, adverse genetic 
and environmental influences can 
impose severe constraints on 
growth. IUGR resulting from con-
genital infection, genetic or chro-
mosomal defects, and/or drugs 
and other environmental insults is 	 4*, 
likely to be associated with long- 
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Letter to the Editor 
Russell-Silver Syndrome 
In Vol. 2, No. 2 of Growth, Genet-
ics, and Hormones, an article by 
Saal et al entitled "Reevaluation of 
Russell-Silver Syndrome" was ab-
stracted. The Editor's Comment on 
that abstract prompts this letter. 
One of the reasons that the 
Russell-Silver syndrome is hetero-
geneous is that there is no such 
thing as the Russell-Silver syn-
drome. Dr. Russell and Dr. Silver, 
in their original reports, described 
two entirely different syndromes. It 
is a mistake to combine the two 
and perpetuate the combination. I 
have mentioned this to Dr. Alex 
Russell, who agrees. Dr. Silver 
even described increased urinary 
gonadotropins in his patients. I 
point this out to our house staff 
when they refer such a patient to 
our clinic. In my experience, most 
of the patients referred to me for 
dwarfism, triangular facies, and in-
trauterine growth retardation fall 
into the "Russell" category. I have 
yet to see a patient with increased 
gonadotropins at a young age in 
the hemihypertrophy syndrome 
described by Silver. I continue to 
be a splitter instead of a lumper. 
Orville C. Green, M.D. 
Professor of Pediatrics 
Children's Memorial Hospital 
Chicago, Illinois 
Dr. Blizzard's Comments 
Dr. Green's letter is in accord with 
the article written by Saal et al and 
published in the Journal of Pediat-
rics 1985;107:733. These authors 
stated that the Russell-Silver syn-
drome is a heterogeneous entity. 
Dr. Green would say it is not an 
entity at all. Undoubtedly, many 
would agree with Dr. Green. I have 
asked Dr. Silver to respond and his 
comments are listed below. 
Dr. Silver's Comments 
The confusion about the Silver- 
Russell syndrome will un- 
doubtedly continue until the spe-
cific etiology(s) of the syndrome 
has (have) been defined and/or a 
specific diagnostic laboratory test 
is available. Although the hetero-
geneity of findings suggests that 
multiple etiologies may be in-
volved, there is no concrete evi-
dence that this is so. 
The Silver-Russell syndrome 
certainly fits the definition of a syn-
drome: "the sum of signs of any 
morbid state; a set of symptoms 
occurring together" (Dorland). As 
with most other syndromes, not 
every child with the Silver-Russell 
syndrome has every finding. How-
ever, the combination of all or most 
of the findings of congenital short 
stature continuing into childhood, 
asymmetry involving various parts 
of the body, triangular facies, cli-
nodactyly, cafe-au-lait areas of the 
skin, syndactyly of the toes, and 
elevated gonadotropins (as first 
described by me in 1953, and in 
subsequent publications, and by 
Russell in 1954) occurs with suffi-
cient frequency to be considered a 
specific syndrome with one or 
more etiologies. 
Originally, the syndrome was 
known as the Silver syndrome in 
this country and the Russell syn-
drome in Europe. More recently, it 
has been termed the Silver-Russell 
syndrome or the Russell-Silver 
syndrome. Hopefully, Drs. Green, 
Saal, and others will soon provide 
us with the information that will 
permit us to make etiology-based 
diagnoses. Until then, I believe it is 
reasonable to continue using the 
names that have historically been 
assigned to what appears to be a 
single clinical syndrome with a 
characteristic phenotype. 
Henry K. Silver, M.D. 
Professor of Pediatrics 
University of Colorado 
School of Medicine 
Denver, Colorado 
term developmental disability. Fe-
tuses with IUGR secondary to in-
trauterine nutritional deprivation 
may have more favorable out-
comes due in large part to adap-
tations such as decreased fetal 
size with sparing of brain growth, 
mild polycythemia, and enhance-
ment of pulmonary maturation. In 
many such infants, IUGR is an ad-
vantageous adaptation rather than 
a pathologic condition. 
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IN FUTURE ISSUES 
The Concepts and Mechanisms 
of Genetic Linkage 
by Thaddeus Kelly, M.D. 
Genetic Linkage and Endocrine 
Disease 
by Thaddeus Kelly, M.D. 
Turner's Syndrome 
by Judith G. Hall, M.D. 
Directory of Resource Groups for 
Patients with Endocrine and Ge-
netic Disorders 
The address given for the Prader-With Syndrome Association in Volume 2, 
Number 3 was in error. The correct address is: 5515 Malibu Drive, Edina, 
Minnesota 55436. The phone number is 612-933-0113. Marge A. Welt is the 
Executive Director. 
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Table Height-Related Statistics in Study Participants 
Anorexic patients 
	 Controls 
Height percentiles n % Expected, % 
<5 12 14 1 1 4 
5-9 3 4 4 5 5 
10-24 28 33 16 19 15 
24-49 22 26 28 33 25 
>50 20 23 36 42 50 
Abstracts From the Literature 
Short Stature in Anorexia 
Nervosa Patients 
In following 104 patients with an-
orexia nervosa, the authors found 
85 suitable for comparison with 85 
age-matched controls. As seen in 
the Table, a large percentage of 
the anorexic patients were short. 
Information was available re-
garding parental heights for 35 pa-
tients. The mean actual height was 
at the 34th percentile, compared 
to a mean expected height at the 
48th percentile, based on calcu-
lations of parental heights. Twenty-
six females were postmenarchal, 
permitting comparison with the ad-
justed mid-parental height (Tanner 
scale). Nine had evidence of 
growth impairment and could not 
be classified under "familial short 
stature" by this method. 
The patients' age at onset of an-
orexia ranged between 10 and 22 
years. Symptoms first appeared 
an average of 12.9 months before 
seeking therapy, and the mean 
weight loss was 29 pounds (25% 
of total body weight). Of great im-
portance in considering the etiol-
ogy of the short stature is the fact 
that 80% developed anorexia after 
menarche, with symptoms of onset  
occurring more than one year 
postmenarche in 61%. 
The conclusion is that some fac-
tor(s) other than malnutrition may 
account for the fairly high inci-
dence of short stature. Possibly, 
there is a pathophysiologic factor 
producing short stature and, sub-
sequently, anorexia. Patients with 
anorexia sometimes exhibit sev-
eral indications of a hypothalamic 
abnormality affecting thyroid, go-
nadal, and adrenal function. The 
authors state that excessive so-
matostatin production cannot be 
excluded. 
Nussbaum M, Baird 0, Son-
nenblick M, et al. J Adolesc Health 
Care 1985;6:453 -455. 
Editor's comment—These data 
are not only important but also 
provocative, since they are unex-
plained within the context of cur- 
rent knowledge. Most patients with 
anorexia might be expected to 
have growth failure secondary to 
malnutrition. In the majority of 
these patients, growth retardation 
preceded malnutrition. Growth 
hormone levels are increased in 
most patients with anorexia, al-
though IGF-1 values are low, as is 
expected with starvation. We do 
not know whether GH and 1GF-I 
levels are normal before the onset 
of anorexia. If available, these data 
might provide insight regarding 
the etiology of anorexia nervosa. 
Furthermore, could these pa-
tients have hypercortisolism long 
before the anorexia begins? (See 
the review of the endocrine sym- 
posium on neuropsychiatric dis- 	 "irie 
orders, reported by Dr. Lifshitz in 
this issue.) if present, hyper- 
cortisolism could account for the 
growth retardation. 
Hypercalciuria, Hyperphos-
phaturia, and Growth Retar-
dation in Children With Di-
abetes Mellitus 
The authors evaluated 157 dia-
betic children, 6 to 16 years of age, 
with insulin-dependent diabetes 
mellitus (IDDM) from 0.2 to 14 
years. Eleven percent of the 157 
subjects were shorter than would 
be anticipated, as assessed by 
comparison with the controls. In-
crements in height became 
smaller with the duration of IDDM 
and differed significantly from con-
trols when IDDM had been present 
for more than seven years. 
Growth retardation correlated 
with increased calcium and phos-
phorus excretion (as reflected by 
increased Ca/Cr and P/Cr ratios) 
and with poor control of IDDM (as 
evidenced by glycosylated hemo- 
globin assays). Hypercalciuria 
was not correlated with increased 
serum calcium or other evidence 
of bone calcium mobilization. Hy-
percalciuria is reportedly caused 
by hypophosphatemia, and there 
was an inverse relationship be-
tween serum phosphorus and an 
increase of urinary P/Cr and Ca/Cr. 
Renal disease could not be dem-
onstrated as a cause of increased 
Ca and P excretion when it oc-
curred. The urinary loss of Ca also 
correlated inversely with plasma 
glucose at the time of urine collec-
tion. The increased urinary phos-
phorus appears to result from 
competition between glucose and 
both Ca and P for renal tubular 
reabsorption. There was some ev-
idence of hypercalciuria as a renal 
response to functional phospho-
rus deficiency. 
The authors conclude that the 
higher incidence of short children 
with IDDM is primarily associated 
with poor metabolic control, but 
the specific mechanism(s) of im-
paired growth is (are) not well de-
fined and may not be due to a 
single cause. 
Malone JI, Lowitt S, Duncan JA, et 
al. Pediatrics 1986;78:298. 
Editor's comment—This study 
is very well done and carefully ana-
lyzed. The authors speculate 
that phosphorus supplementation 
might be beneficial. Further stud-
ies are certainly indicated to eluci-
date the causes and results of 
hypercalciuria and hyperphos-
phaturia, which are frequently 
seen in patients with poorly con-
trolled IDDM. (See Harrison's arti-
cle in Growth, Genetics, and Hor-
mones, vol. 2, no. 2.) 
440 
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Abstracts rrom The Literature 
First Trimester Prenatal 
Diagnosis: Three Reports 
Prenatal diagnosis of severe con-
genital diseases and malforma-
tions, which permits selective ter-
mination or altered management 
of affected pregnancies, has be-
come an accepted part of modern 
medical practice. In the 1970s, 
amniocentesis and real-time ul-
trasound evaluation of the fetus 
during the second trimester were 
introduced for prenatal diagnosis. 
In the early 1980s, first trimester 
sampling of the chorionic villus 
(the fetal part of the placenta) was 
developed as an alternative mo-
dality for prenatal diagnosis. By 
the end of 1985, sampling proce-
dures of more than 1,000 chorionic 
villi had been performed for pre-
natal diagnosis during the first tri-
mester in ongoing pregnancies. 
The article by Jackson in Semi-
nars in Perinatologl reviews the 
technique and the indications for 
first trimester chorionic villus sam-
pling. The technique involves 
calization of the placenta with ul-
trasound, and the vaginal removal 
(by suction under ultrasonic su-
pervision). The test is most easily 
and safely done between the be-
ginning of the 9th week and the 
end of the 11th week of gestation. 
Chromosomal, DNA, and most 
biochemical assays can be done 
on chorionic villus material, and 
411.01 the results of such testing are usu-
ally available within the first 
trimester. 
The safety and accuracy of 
chorionic villus sampling have 
been established by the Internal 
Chorionic Villus Sampling (CVS) 
Registry, which was established 
by Jackson et al two years ago.2 It 
is now clear from these data that 
the incidence of significant com-
plications after CVS is less than 
5%. In institutions with experience 
in the technique, the miscarriage 
rate after CVS is between 2% and 
4%. The background spontaneous 
abortion rate is approximately 2% 
or 3%. Thus, additional risk of CVS- 
111' 
	
	 caused miscarriage seems small 
and is probably in the range of 1%.  
Separation of fetal from maternal 
tissue is extremely important for 
accurate CVS results. One com-
plication that has been observed is 
a higher rate of chromosomal 
mosaicism in chorionic tissue than 
in amniotic tissue. 
Transabdominal CVS has re-
cently been described by Smidt-
Jensen et al.3 It may be that this 
technique will avoid or minimize 
occurrence of infection, which has 
occasionally been seen in vaginal 
sampling. 
1. Jackson L. Semin Perinatol 
1985;9(3) :209-218. 
2. Jackson LG, Wapner RA, Barr 
MA. Lancet 1986;i:674-675. 
3. Smidt-Jensen S, Hahnemann N, 
Influences in Child Growth 
Associated With Poverty in 
the 1970s: An Examination of 
Hanes I and Hanes II, Cross-
Sectional U.S. National 
Surveys 
The association between poverty 
and growth deficits in children has 
been reported in developing coun-
tries as well as in the United States. 
In this study, a sample population 
of 13,750 black and white children 
aged 1 to 17 years was taken from 
the Health and Nutrition Examina-
tion Surveys, HANES I (1971-
1975) and HANES II (1976-1980). 
These were employed to examine 
the associations between height, 
weight, triceps skinfold thickness, 
subscapular skinfold thickness, 
and dietary intake measures. The 
poverty index ratio (PIR) was used 
to define the poverty threshold. 
This index represents a more spe-
cific measure of poverty than in-
come by including family size and 
composition, sex of head of 
household, farm/nonfarm resi-
dence, and the current Consumer 
Price Index. The PIR is widely 
used by the U.S. Government. 
Overall, children above the pov-
erty threshold were taller, heavier, 
and fatter than children in families 
living below the poverty level. 
Specifically, on the average, poor 
children were 1.3 to 1.9 cm  
Hahn J, et al. Prenat Diagn 1986; 
6:125-132. 
Editor's comment—There are 
several advantages to first trimes-
ter prenatal diagnosis. These in-
clude safety for the mother if termi-
nation of pregnancy is deemed 
necessary and a chance to con-
firm results by second trimester 
amniocentesis, if appropriate. Ear-
lier testing is also easier to handle 
psychologically for most families. 
Since prenatal diagnosis is 
available and since it can be ap-
plied to detect many types of 
growth problems, physicians 
should be aware of these new ad-
vances and the availability of first 
trimester diagnostic techniques. 
shorter, 2% to 3% lighter in weight, 
and 3% to 8% leaner (by skinfold 
measurements) than children 
above the poverty level. An inter-
esting finding was that there were 
no reported differences in energy 
consumption and macronutrient 
intakes between the two groups. 
However, a trend toward improved 
growth among the poor children 
was noted between the time of the 
HANES I (1971-1975) and HANES 
II (1976-1980) surveys. 
Jones DY, Nesheim MC, Habicht 
JP. Am J Clin Nutr 1985;32: 
714 -724. 
Editor's comment—This study 
suggests that caloric intake does 
not appear to play a role in the 
growth failure reported among 
poor children. Both groups of chil-
dren consumed equal diets, yet 
children who were below the pov-
erty threshold were smaller in both 
weight and height, and had less 
reserve fat as measured by skin-
fold thickness than children above 
the poverty threshold. Other fac-
tors that may be associated with 
poverty, such as more frequent in-
fections, insufficient medical care, 
and poor sanitation, may have had 
a negative influence on the growth 
of the children below the poverty 
threshold. The authors, however, 
do not discuss these concerns as 
they relate to growth. 
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Special Report: The Endocrine Society Symposium on Endocrinology of 
Neuropsychiatric Disorders—June 25-27, 1986, Anaheim, California 
Fima Lifshitz, M.D. 
Associate Editor—Growth, Genetics, and Hormones 
The symposium dealt primarily 
with the interrelationship of nutri-
tion, neuropsychiatric disorders, 
and endocrinology. Dr. John E. 
Morley of the University of Cali-
fornia at Los Angeles pointed out 
that many peptide hormones are 
involved in the control of human 
eating behavior. For example, 
cholecystokinin-8 has been called 
a satiety factor because of its abil-
ity to decrease feeding and delay 
gastric emptying through vagal 
activity, Dr. Morley also noted that 
glucagons, somatostatin, born-
besin, calcitonin, naloxone, and 
other opioid antagonists act 
centrally 	 as 	 satiety 	 factors. 
Corticotropin-releasing factor is 
also a potent anorectic agent. 
Peptides that enhance feeding 
behavior include the endogenous 
opioids, pancreatic polypeptide, 
galinin, growth-hormone-releas-
ing hormone, and neuropeptide Y 
(bulimin). 
Dr. Michelle P. Warren of St. 
Luke's-Roosevelt Hospital, New 
York City, discussed endocrine 
changes associated with anorexia 
nervosa. Dr. Warren stated that the 
incidence of anorexia nervosa ap-
pears to be increasing. It afflicts 
between 0.5% and 1.0% of white 
adolescents who are in the mid-
socioeconomic group. There is a 
6% concordance in incidence 
among monozygotic twins al-
though the reasons for this are 
poorly understood. The peak age 
of onset is at about 12 to 13 years 
of age. For some unexplained rea-
son, anorexia occurs more often in 
girls with scoliosis. The disorder is 
very rare among blacks and 
among men (the male-female ratio 
is 1:9). However, anorexia nervosa 
occurs in males who are training 
for competitive athletic activities 
and are restricting their food in-
take. Between 5% and 20% of pro-
fessional ballet dancers can be  
classified as patients with anorexia 
nervosa. 
The endocrine changes seen in 
anorexia nervosa appear to be 
adaptive phenomena and are sim-
ilar to those seen in starvation. 
These include lower levels of tu-
teinizing hormone (LH) and 
follicle-stimulating hormone (FSH) 
and decreased pulsatility of LH 
over a 24-hour period. The pul-
satility pattern reverts to that seen 
in prepubertal subjects. There is 
also increased secretion of endog-
enous opioids, but administration 
of naloxone restores normal LH 
secretion in only a small number of 
patients. Thyroid function re-
sembles that in the "euthyroid sick 
syndrome," with increased 3:3', 5' 
triiodothyronine concentrations 
and decreased 3, 5, 3' tri-
iodothyronine secretion. This re-
duces the metabolic rate and de-
creases muscle catabolism. Hyper-
cortisolism often occurs because of 
Special Report: National Foundation - March of Dimes Clinical 
Genetics Conference on Muscle and Its Disorders—June 8-11, 1986, Philadelphia 
Judith G. Hall, M.D. 
Associate Editor—Growth, Genetics, and Hormones 
The National Foundation-March of 
Dimes has reinstituted the clinical 
genetics conferences that were so 
successful in the 1960s and 
1970s. The earlier conferences 
focused on the delineation of birth 
defects. However, because of ad-
vances in molecular genetics, de-
velopmental genetics, and clinical 
genetics, a new format became 
desirable. The new March of 
Dimes clinical genetics con-
ferences are aimed at providing a 
better understanding of a particu-
lar organ system. At this year's 
conference, the subject was mus-
cle. Clinical and basic research 
dealing with normal and abnormal 
muscle differentiation, muscle 
biochemistry, and muscle function 
was presented, allowing clinicians 
and researchers to learn from 
each other's work. 
Sir Andrew Huxley convened 
the conference with a historical 
overview of muscle disorders. 
Several presentations on molecu-
lar research related to the actin 
and myosin genes followed. Not 
only have these genes been 
mapped and their differences de-
scribed, but the progressive 
switching on and off during devel-
opment and in different tissues is 
becoming well defined. The map-
ping of specific genes that are 
tightly regulated during embryo-
logic and fetal development was 
clearly outlined at the meeting. 
Much of this work has been done in 
culture of muscle cells, but there 
seemed to be correlations in dif-
ferent animal model systems and 
in muscle from various sites of the 
body. 
The clinical aspects of well- 
defined muscle disease, both dys-
trophies and metabolic disorders, 
were reviewed. However, a whole 
new set of specific disorders, 
many of which can now be under-
stood on a molecular level, were 
reported by various investigators. 
Various aspects of myogenesis—
both in normal and abnormal cells, 
and during development and in 
regeneration—were discussed, as 
were the interaction of nerve and 
muscle and the biochemistry re-
lated to those interactions. 
Experiments of nature—in which 
individuals with muscular dystro-
phy have also been growth-
hormone-deficient or have had 
denervation, as by polio, but have 
not developed the usual muscle 
deterioration—indicate that many 
environmental factors can affect 
genetically determined muscle 
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decreased clearance of free car-
tisol ,and it is presumed that there is 
increased secretion of corticotro-
pin-releasing factor (CRF). Growth 
hormone is increased, but somato-
medin-C (IGF-I) levels are de-
creased; this may conserve nitro-
gen. There is increased sensitivity 
to insulin, and norepinephrine se-
cretion is reduced. Vasopressin 
also appears to be reduced and 
this may cause difficulty in han-
dling water loads. 
Consequences of the amenor-
rhea induced by starvation may be 
#4,2 osteoporosis, stress fractures, and 
aseptic hip necrosis. All of these 
conditions are much more com-
mon in patients with anorexia than 
in normal females. Osteoporosis 
may result from scoliosis, but sco-
liosis may actually precede an-
orexia, an interesting observation. 
Dr. George F. Koob of the 
Scripps Clinic and Research 
\sr 
	 Foundation in La Jolla, California,  
discussed behavioral and endo-
crine effects of CRF on the central 
nervous system (CNS). CRF is a 
potent stimulus for both adre-
nocorticotropic hormone (ACTH) 
and beta-endorphin release. It has 
also been shown to increase CNS 
activity in a manner much like that 
of caffeine, and it potentiates the 
acoustic startle response. CRF 
also affects the limbic system, with 
its primary effects on learning and 
behavioral pathology, aggression, 
and changes in sexual behavior. 
Another presentation at the 
symposium dealt with the patho-
physiology of hypothalamic-pitu-
itary-adrenal dysfunction in de-
pression and anorexia nervosa. 
Dr. Philip W. Gold of the National 
Institute of Mental Health of the 
National Institutes of Health in Be-
thesda, Maryland, reported that 
hypothalamic dysfunction has 
been shown to be present in an-
orexia nervosa and depression.  
Moreover, the hypercortisolism 
present in both disorders appears 
similar in pathophysiology, but dif-
ferent from that observed in Cush-
ing's disease. Dr. Gold stated that 
in both depression and anorexia 
nervosa, there is probable in-
creased secretion of endogenous 
CRF, attenuated ACTH responses 
to CRF, and adrenal hyper-
responsiveness to ACTH. These 
abnormalities resolve when the 
patients gain weight. The hyper-
cortisolism in depression and an-
orexia nervosa represents a cen-
tral defect, whereas the hypercor-
tisolism of Cushing's disease is 
believed to be caused by a defect 
of excessive ACTH secretion that 
seems to be localized in the pitu-
itary. Dr. Gold and his co-workers 
believe that endogenous CRF se-
cretion in patients with depression 
and anorexia nervosa may be sig-
nificant in the symptom complexes 
of these illnesses. 
function and deterioration. It ap-
pears that the size of muscle cells 
in Duchenne's muscular dystro-
phy may be critical in the dystro-
phic process. Growth hormone 
deficiency can slow the rate of 
progression of muscular dystro-
phy, possibly by limiting the size of 
the muscle cell. This and other 
observations give hope that new 
approaches to symptomatic ther-
apy can be found. Fortunately, 
new techniques for studying mus- 
cle size, composition, and func-
tion, such as nuclear magnetic 
resonance, are beginning to yield 
clues about normal muscle physi-
ology at the molecular level and 
about the distribution of abnormal-
ities within the muscle cells. 
Many well-known syndromes 
W110 	 in which the etiology has not 
been defined—such as Marfan,  
Schwartz-Jampel, and Marinesco-
Sjogren syndromes—were exam-
ined as possible muscular 
dystrophies. 
Perhaps the most exciting re-
cent advance has been the mo-
lecular analysis of the Duchenne's 
muscular dystrophy gene locus. 
Two approaches have been used: 
that of "walking" along the X chro-
mosome and the use of DNA from 
girls with Duchenne's muscular 
dystrophy who have X-autosome 
translocations that can be studied 
on a molecular level. The area of 
the Duchenne gene is now starting 
to be "peppered" with probes that 
allow prenatal diagnosis and car-
rier detection. It is now considered 
likely that the gene locus for Beck-
er's muscular dystrophy is either 
within or very close to that for Du-
chenne's muscular dystrophy.  
Linkage analysis of other myopa-
thies and muscle problems is im-
proving as well. For example, the 
linkage of myotonic dystrophy, by 
using more closely linked genes, 
now enables much more accurate 
prenatal diagnosis and premorbid 
recognition. 
In general, the conference was 
exciting and stimulating, because 
it encouraged interaction between 
basic research scientists and cli-
nicians. It is exciting to see how 
much progress has been made in 
an area in which new findings and 
techniques can be rapidly applied 
to clinical conditions. We look for-
ward to seeing this same ap-
proach being used in future March 
of Dimes conferences to elucidate 
other organ systems. In this way, 
birth defects and genetic diseases 
will be further delineated. 
tomil 
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